Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $16.2 Million - $20.2 Million
-69,101 Reduced 47.28%
77,059 $21.7 Million
Q1 2022

May 12, 2022

BUY
$221.42 - $260.97 $12 Million - $14.2 Million
54,275 Added 59.07%
146,160 $38.1 Million
Q4 2021

Feb 03, 2022

BUY
$177.01 - $223.45 $16.3 Million - $20.5 Million
91,885 New
91,885 $20.2 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track M.D. Sass Investors Services, Inc. Portfolio

Follow M.D. Sass Investors Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M.D. Sass Investors Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M.D. Sass Investors Services, Inc. with notifications on news.